Elon Musk invests on Covid-19 vaccine!
Pandemic does not slow down for a moment. Everything indicates that the worst is yet to come. However, a light appeared in the tunnel in the form of Tesla, thanks to which it may be possible to quickly manage the situation before it is too late.
Elon Musk and his team of engineers from Tesla filed a patent for the construction of an RNA bioreactor, with which it will be possible to create chemical reactions related to the transformation of DNA into RNA and tests of the first specifics based on matrix RNA. The billionaire is to build mini-factories for such vaccines. They will allow you to carry out drug tests and then produce hundreds of millions of vaccines in a short time.
To this end, Tesla has established cooperation with the German company CureVac. It got loud about it two months ago, when it was the first in the world to announce that she would release an effective vaccine for CoVID-19. The technology developed by CureVac is to be groundbreaking, as it will be the first mRNA vaccine, i.e. it will have an amazing 100% efficiency.
CureVac is in the process of developing technology, thanks to which humanity will not only be able to successfully fight the SARS-CoV-2 coronavirus, but also to overcome almost all the most dangerous diseases. The breakthrough technology is based on the so-called mRNA, or matrix RNA. Last year, CureVac researchers designed a prototype mRNA printing platform.
It allows you to print a specific code for human cells, which reprograms them in such a way that they perform specific functions exactly as we want. This means that our bodies will be able to produce medicines for themselves and thus heal themselves from virtually every disease. This is the technology of the future, which is currently in advanced development.
The company also wants to create universal cancer drugs and vaccines, e.g. influenza, which will work 10 years ahead with the help of mRNA technology. Supercomputers and artificial intelligence will be very helpful here, with the help of which it will be possible to simulate and encode information in mRNA to fight future virus mutations.
Experts point out that this technology has so much potential that the world's largest countries and concerns are interested. It is worth emphasizing here that the head of Amazon, Jeff Bezos, the Bill and Melinda Gates foundation, as well as the American Agency for Advanced Research Projects in the Area of Defense (DARPA) invest in the project.